FDA Drug Recalls

1,724 recalls · Class II, newest first

Mar 25, 2016 Class II · Moderate risk

All budesonide Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1087-2016

Mar 25, 2016 Class II · Moderate risk

All cetirizine Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1086-2016

Mar 25, 2016 Class II · Moderate risk

All arginine Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1085-2016

Mar 25, 2016 Class II · Moderate risk

All T4-levothyroxine Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1084-2016

Mar 25, 2016 Class II · Moderate risk

All thymol Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1083-2016

Mar 25, 2016 Class II · Moderate risk

All PCCA Lipoderm Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1082-2016

Mar 25, 2016 Class II · Moderate risk

All tetracaine Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1081-2016

Mar 25, 2016 Class II · Moderate risk

All propylparaben Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1080-2016

Mar 25, 2016 Class II · Moderate risk

All methimazole Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1079-2016

Mar 25, 2016 Class II · Moderate risk

All fluocinonide Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1078-2016

Mar 25, 2016 Class II · Moderate risk

All Germall

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1077-2016

Mar 25, 2016 Class II · Moderate risk

All betamethasone diproprionate Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1076-2016

Mar 25, 2016 Class II · Moderate risk

All monobenzone Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1075-2016

Mar 25, 2016 Class II · Moderate risk

All carbomer Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1074-2016

Mar 25, 2016 Class II · Moderate risk

All progesterone Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1073-2016

Mar 25, 2016 Class II · Moderate risk

All Peterson Cream Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1072-2016

Mar 25, 2016 Class II · Moderate risk

All TRIE Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1071-2016

Mar 25, 2016 Class II · Moderate risk

All estriol Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1070-2016

Mar 25, 2016 Class II · Moderate risk

All testosterone Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1069-2016

Mar 25, 2016 Class II · Moderate risk

All 4-aminopyridine Products

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1067-2016

Nov 29, 2015 Class II · Moderate risk

Oxygen

cGMP Deviations; trailer may not have met GMP requirements prior to filling

Terminated cGMP deviation AGA Gas Inc NDC 33237-001-01 D-0779-2016

Oct 15, 2015 Class II · Moderate risk

Screenses Color Sunscreen

cGMP Deviations; product does not comply with cGMP requirements

Ongoing cGMP deviation Sesderma, SL D-0851-2016

Oct 15, 2015 Class II · Moderate risk

Screenses Color Sunscreen Tinted facial make-up compact

cGMP Deviations; product does not comply with cGMP requirements

Ongoing cGMP deviation Sesderma, SL D-0850-2016

Oct 15, 2015 Class II · Moderate risk

Repaskin 30

cGMP Deviations; product does not comply with cGMP requirements

Ongoing cGMP deviation Sesderma, SL NDC 63181-0010-1 D-0849-2016

Oct 15, 2015 Class II · Moderate risk

Repaskin 50

cGMP Deviations; product does not comply with cGMP requirements

Ongoing cGMP deviation Sesderma, SL NDC 63181-0011-1 D-0848-2016

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061